Another promising therapy, NK4, an intra-molecular fragment of HGF, has been shown to possess anti-growth, anti-metastasis, anti-angiogenic abilities in addition to showing reduction in ascites, thereby prolonging survival in an orthotopic mouse model of pancreatic cancer [115,116]. The gene discussed is IL32; the disease is pancreatic neoplasm.